Evidence map›Paper›PMID 35922526›Full record

ArticleScientific reports2022

Development of a diagnostic assay by three-tube multiplex real-time PCR for simultaneous detection of nine microorganisms causing acute respiratory infections.

Xi-Wen Jiang, Tao-Sheng Huang, Long Xie, Si-Ze Chen, Shi-Dong Wang, Zhi-Wen Huang, Xin-Yu Li, Wei-Ping Ling

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Global research trends ofFrontiers in pediatrics · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Xi-Wen Jiang *Research Institute, DAAN Gene Co., Ltd., No. 19 Xiangshan Road, Guangzhou, China. yuanyecat@vip.sina.com.
Tao-Sheng Huang *Research Institute, DAAN Gene Co., Ltd., No. 19 Xiangshan Road, Guangzhou, China.
Long Xie *Clinical and Translational Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Si-Ze ChenCentral Laboratory, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
Shi-Dong WangResearch Institute, DAAN Gene Co., Ltd., No. 19 Xiangshan Road, Guangzhou, China.
Zhi-Wen HuangResearch Institute, DAAN Gene Co., Ltd., No. 19 Xiangshan Road, Guangzhou, China.
Xin-Yu LiResearch Institute, DAAN Gene Co., Ltd., No. 19 Xiangshan Road, Guangzhou, China.
Wei-Ping LingResearch Institute, DAAN Gene Co., Ltd., No. 19 Xiangshan Road, Guangzhou, China.
Ministry of Health · PLFirst Affiliated Hospital of Guangdong Pharmaceutical University · CNNewcastle University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute respiratory infections are widespread in vulnerable populations of all ages and are characterized by a variety of symptoms. The underlying infection can be caused by a multitude of microorganisms, including viruses and bacteria. Early detection of respiratory infections through rapid pathogen screening is vital in averting infectious respiratory disease epidemics. This study utilized a multiplex real-time PCR system to develop a three-tube reverse transcription-PCR (RT-PCR) assay, enabling simultaneously detect nine respiratory pathogens, including: influenza A and B, adenovirus, respiratory syncytial virus (RSV), Streptococcus pneumoniae, Legionella pneumophila, Haemophilus influenzae, Chlamydia pneumoniae, and Mycoplasma pneumoniae. This technique utilizes a one-step assay, with specifically designed TaqMan primer-probe sets combined in the same tube. This assay provided rapid and simplified detection of the nine prevalent pathogens, as well as increased sensitivity and reduced cross-contamination. This assay was evaluated using 25 related viral/bacterial strains as positive references, the other 25 irrelevant strains as negative controls, and clinical specimens from 179 patients. All positive strains were detected with no amplification of the non-target microorganism mixtures and the assay's detection limits ranged between 250-500 copies/ml (1.25-2.5 copies/reaction). A total of 167 (93.3%) samples tested positive for at least one of the pathogens identified; 109 of these samples were from patients confirmed to have RSV infections. The diagnostic accuracy of our assay was further confirmed by matching results from classical direct immunofluorescence assay and nucleotide sequencing. These data demonstrate the innovative multiplex real-time PCR assay as a promising alternative to the current approaches used for early screening of acute respiratory infections.

Indexed as

Chlamydophila pneumoniaeRespiratory Syncytial Virus, HumanRespiratory Tract InfectionsVirusesHumansMultiplex Polymerase Chain ReactionReal-Time Polymerase Chain ReactionSensitivity and Specificity

Identifiers

PMID35922526
PMCPMC9427838
OpenAlexW4289544314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.